---
$id: https://graph.org.ai/products/commodity/51161548
$type: Product
source: UNSPSC
code: "51161548"
title: "Nepadutant"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Nepadutant

**UNSPSC Code**: 51161548
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-asthmatic agent with the molecular formula C45H58N10O13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XW59TYL1XH, chemically known as men-11,420 but generally known as nepadutant, which bears US NIH Compound Identifier 3086682. European Medicines Agency schedules Nepadutant in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09196MIG. The term NEPADUTANT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). NEPADUTANT is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nepadutant under HS 29349990 and SITC 51579. As of Q4 2014, NEPADUTANT remains the US FDA Preferred Term for this commodity. Nepadutant bears US NLM identifiers UMLS ID C0664922 and NCI Concept Code C84001. SMILES: O1C(NC(=O)CC(N)C(=O)NC2CC(=O)NCC(NC(=O)C(NC(=O)C(NC2=O)CC2C3C([NH]C2)CCCC3)CC2CCCCC2)C(=O)NC(CC(C)C)C(=O)O)C(NC(=O)C)C(O)C(O)C1CO.

